Oil prices hold sharp losses with focus on secondary India tariffs
In the latest trading session, Cathie Wood’s ARK ETFs continued to adjust their portfolios, with significant moves seen in both buying and selling across various sectors. The largest transaction for Wednesday, February 5th, 2025, involved a substantial purchase of CRISPR Therapeutics AG (NASDAQ:CRSP) shares, indicating a strong vote of confidence in the gene-editing company from ARK Invest.
ARK’s flagship fund, ARKK, and its genomics-themed ARKG, bought a combined total of 187,338 shares of CRISPR Therapeutics AG, valued at approximately $7.59 million. This move underscores ARK’s ongoing interest in the biotech sector and its potential for disruptive innovation.
Conversely, ARK’s most significant sale for the day was of Robinhood Markets Inc (NASDAQ:HOOD), with ARKK divesting 127,952 shares worth nearly $6.73 million. This sale might signal a strategic shift or a response to recent market dynamics around the trading platform’s stock.
Other notable trades included the sale of 99,514 shares of Accolade Inc (NASDAQ:ACCD) for about $687,641 through the ARKG ETF, continuing a selling trend observed in previous sessions for the healthcare services company.
In addition, ARK also increased its holdings in Twist Bioscience Corp (NASDAQ:TWST) and 10X Genomics Inc (NASDAQ:TXG), purchasing 15,291 and 77,594 shares valued at approximately $795,437 and $1.12 million, respectively. These acquisitions align with ARK’s focus on cutting-edge genomic technologies.
Smaller transactions for the day involved a sale of 550 shares of Adyen (AS:ADYEN) NV (OTC:ADYEY) for just over $9,000 via the ARKW ETF, and a minor sale of 100 shares of Lockheed Martin Corp (NYSE:LMT) totaling around $45,367 through the ARKQ ETF. Additionally, ARKW sold a mere 50 shares of Nu Holdings Ltd (NYSE:NU) at a value of $665, and ARKK offloaded 5,495 shares of Palantir Technologies Inc (NYSE:NASDAQ:PLTR) for about $570,545.
These daily trades provide insight into ARK’s strategic adjustments and the investment firm’s perspective on market opportunities and risks. Investors and market watchers will continue to monitor ARK’s moves closely, as Cathie Wood’s ETFs are known for their focus on disruptive innovation and for taking bold positions in their chosen sectors.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.